Form 4 for NRC NRC HEALTH
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001567619-23-000524 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | NRC | Hays Michael D. | CEO, Pres, Dir | M - OptEx | $14.50 | +10.9K | 45.0K | +32% | +$158.6K |
| D | 2023-01-05 | 2023-01-03 | NRC | Hays Michael D. | CEO, Pres, Dir | M - OptEx | $0.00 | -10.9K | 0 | -100% | $0 |
| D | 2023-01-05 | 2023-01-04 | NRC | Hays Michael D. | CEO, Pres, Dir | A - Grant | $0.00 | +4,909 | 4,909 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | M | A | 10,938 | $14.50 | 45,040 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-01-03 | M | D | 10,938 | $0.00 | 0 | D | $14.50 · 2013-01-07 to 2023-01-07 | 10,938 Common Stock | (F2) This option was previously reported as covering 3,646 shares at an exercise price of $52.42 per share, but was adjusted to reflect the stock dividend that occurred on May 22, 2013. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 4,909 | $0.00 | 4,909 | D | $38.93 · — to 2033-01-04 | 4,909 Common Stock | (F3) This option becomes fully exercisable on January 4, 2028. |